Home›Search›Frontiers in Bioscience - Landmark

Frontiers in Bioscience - Landmark

IMR Press Limited · Hong Kong · Est. 2009

ISSN2768-6701eISSN2768-6698

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1 · Scopus CiteScore 5.7. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.915

H-Indexi

CiteScorei

5.7

SNIPi

0.64

Total Worksi

1,758

Total Citationsi

13,573

2yr Mean Citednessi

3.75

Open Impact Factor alternative

Aims & Scope

Frontiers in Bioscience-Landmark (FBL) is an international, peer-reviewed, open-access bioscience journal focused on cellular and molecular biology. FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. The journal provides a platform for delivering scientific information to investigators, scientists, physicians, lecturers, and students. FBL welcomes submissions of original research articles, reviews, systematic reviews, short communications, and editorials.

General Information

Country / RegionHong Kong

Primary LanguageEnglish

1st Year Published2009

Frequency12 issues per year

StatusActive (last: 2026)

Total Publications1,758

Publisher OrgIMR Press

OA Since2020

Visit Journal Website

Submission Info

Peer ReviewDouble-blind

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

CLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

IMR Press Limited

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2768-6701 / 2768-6698

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2009

149

2.3k

2021

339

2022

369

3.9k

2023

430

3.4k

2024

380

1.3k

2025

231

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q1

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q2

Immunology and Microbiology (miscellaneous)Q2

Subject Classification

Web of Science Categories

Biochemistry & Molecular BiologyCell Biology

Scopus Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Immunology and Microbiology (miscellaneous)Medicine (miscellaneous)

Research Topics (OpenAlex)

Ferroptosis and cancer prognosisCancer, Hypoxia, and MetabolismImmune cells in cancerRNA modifications and cancerCancer-related molecular mechanisms researchEpigenetics and DNA MethylationMicroRNA in disease regulationAutophagy in Disease and TherapyExtracellular vesicles in diseaseNeuroinflammation and Neurodegeneration Mechanisms

Frequently asked questions about Frontiers in Bioscience - Landmark

Is Frontiers in Bioscience - Landmark a predatory journal?

PubScope has no integrity flags on record for Frontiers in Bioscience - Landmark: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Frontiers in Bioscience - Landmark?

Frontiers in Bioscience - Landmark is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. As an open alternative, its Scopus CiteScore is 5.7.

Is Frontiers in Bioscience - Landmark indexed in Scopus and Web of Science?

Frontiers in Bioscience - Landmark is indexed in Web of Science, Scopus, DOAJ.